Skip to main content
. 2013 Apr;345(1):125–138. doi: 10.1124/jpet.112.201558

Fig. 3.

Fig. 3.

Plasma pharmacokinetic distribution of C-DIM compounds. Plasma concentrations for C-DIM compounds and relationship between the route of exposure and plasma concentration. Points represent mean plasma level for either intravenous (red) or oral gavage (black) of C-DIM5 (A), C-DIM 7 (B), C-DIM8 (C), or C-DIM12 (D) over a period of 12 hours (n = 3 animals per time point for each route of exposure) data are expressed as mean ± S.E.M.